You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9) Antibodies

The protein encoded by TNFSF9 is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. Additionally we are shipping TNFSF9 Proteins (36) and TNFSF9 Kits (6) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
TNFSF9 353218  
TNFSF9 21950 P41274
TNFSF9 8744 P41273
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-TNFSF9 Antibodies at antibodies-online.com

Showing 10 out of 198 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IF (p), IHC (p), WB 100 μL Log in to see 3 to 7 Days
$269.50
Details
Human Mouse Un-conjugated ICC, FACS, ELISA, WB Western blot analysis of human CD137L using anti-CD137L (human), mAb (41B436)  at 1:2,000dilution. 1: Recombinant humanCD137L (FLAG ® -tagged). 2: Recombinant mouse CD137L (FLAG ® -tagged). FACS: Human CD137L-transfected HEK 293 cells were stained significantly using anti-CD137L (human), mAb (41B436) . No binding was detected on empty vector transfected cells. 100 μg Log in to see 5 to 8 Days
$330.75
Details
Mouse Rat PE FACS   25 Tests Log in to see 6 to 8 Days
$253.00
Details
Mouse Rat Un-conjugated FACS, IP   25 μg Log in to see 6 to 8 Days
$176.00
Details
Human Rabbit Un-conjugated WB WB Suggested Anti-TNFSF9 AntibodyTitration: 1.0 µg/mL  Positive Control: HepG2 Whole Cell 100 μL Log in to see 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated IF, ELISA, WB Western blot analysis of extracts from HuvEc cells, using TNFSF9 Antibody. The lane on the right is treated with the synthesized peptide. Immunofluorescence analysis of HeLa cells, using TNFSF9 Antibody. The picture on the right is treated with the synthesized peptide. 100 μg Log in to see 2 to 3 Days
$302.50
Details
Mouse Rat Biotin FACS 50 μg Log in to see 10 to 12 Days
$76.09
Details
Human Rabbit Un-conjugated WB 100 μL Log in to see 8 to 10 Days
$507.83
Details
Human Mouse Un-conjugated FACS, WB FACS: Human CD137L-transfected HEK 293 cells were stained significantly using anti-CD137L (human), mAb (41B446) . No binding was detected on empty vector transfected cells. Western blot analysis of human CD137L using anti-CD137L (human), mAb (41B446)  at 1:2,000dilution. 1: Recombinant human CD137L (FLAG ® -tagged). 2: Recombinant mouse CD137L (FLAG ® -tagged). 50 μg Log in to see 5 to 8 Days
$246.75
Details
Human Mouse PE ELISA 100 Tests Log in to see 10 to 12 Days
$250.03
Details

TNFSF9 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Rat (Rattus) ,


Mouse (Murine) , , , ,
,
,
, , , , , , , , , , , , , , , , , , ,
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,

Top referenced anti-TNFSF9 Antibodies

  1. Mouse (Murine) Monoclonal TNFSF9 Primary Antibody for FACS - ABIN2660885 : Pollok, Kim, Kwon: Regulation of 4-1BB expression by cell-cell interactions and the cytokines, interleukin-2 and interleukin-4. in European journal of immunology 1995 (PubMed)
    Show all 10 references for ABIN2660885

  2. Human Monoclonal TNFSF9 Primary Antibody for ELISA - ABIN2662905 : DeBenedette, Shahinian, Mak, Watts: Costimulation of CD28- T lymphocytes by 4-1BB ligand. in Journal of immunology (Baltimore, Md. : 1950) 1997 (PubMed)
    Show all 5 references for ABIN2662905

  3. Mouse (Murine) Monoclonal TNFSF9 Primary Antibody for FACS, IP - ABIN320112 : Goodwin, Din, Davis-Smith, Anderson, Gimpel, Sato, Maliszewski, Brannan, Copeland, Jenkins: Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. in European journal of immunology 1993 (PubMed)

  4. Human Monoclonal TNFSF9 Primary Antibody for ICC, FACS - ABIN1169256 : Gullo, Koh, Pang, Ho, Tan, Schwarz: Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling. in PLoS ONE 2010 (PubMed)

More Antibodies against TNFSF9 Interaction Partners

Mouse (Murine) Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9) interaction partners

  1. 4-1BBL can restrain effector T cell development, creating a more favorable regulatory T cell to effector cell balance under tolerogenic conditions, and this may be particularly active in mucosal barrier tissues

  2. These results demonstrate that 4-1BBL-engineered DCs can improve CIKs (show TRAF3IP2 Antibodies) cytotoxicity against prostate cancer cells.

  3. these observations suggest that inhibition of the TLR/4 (show TLR4 Antibodies)-1BBL complex formation may be highly efficient in protecting against continued inflammation

  4. 4-1BB (show TNFRSF9 Antibodies) mediates the inflammatory responses in obese skeletal muscle by interacting with its ligand 4-1BBL on macrophages.

  5. CD137 (show TNFRSF9 Antibodies)-CD137L interactions mediated via regulation of CyPA (show PPIA Antibodies) contribute to the progression of atherosclerosis.

  6. Data indicate that CD137L deficient mice displayed a variety of immunological dysfunctions.

  7. monocytes interact with iNKT cells to increase expression of 4-1BBL and 4-1BB (show TNFRSF9 Antibodies), and in conjunction with this pathway, maintain their numbers at baseline.

  8. CD137 (show TNFRSF9 Antibodies)-expressing CD4 (show CD4 Antibodies)+ T cells in the bone marrow engage CD137L on hematopoietic progenitor cells, and this CD137L signaling biases hematopoiesis towards myelopoiesis during aging.

  9. TIRAP (show TIRAP Antibodies) and IRAK2 (show IRAK2 Antibodies) are critical for the sustained inflammatory response that is mediated by late-phase signaling by the TLR-4 (show TLR4 Antibodies)-1BBL complex.

  10. Results suggest that CD137L reverse signaling exerts a pro-apoptotic effect by suppressing integrin-mediated survival signals in neural stem cells.

Human Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9) interaction partners

  1. blocking of both OX-40L (show TNFSF4 Antibodies) and 4-1BBL reversed radiation-enhanced T-cell killing of human tumor targets as well as T-cell survival and activation.

  2. CD137L is overexpressed in non-small cell lung cancer specimens and positive expression of CD137L was associated with better overall survival.

  3. In vitro immunotherapy is described for anti-prostate cancer effects of cytotoxic T lymphocytes induction by recombinant adenovirus mediated PSMA/4 (show PSMA4 Antibodies)-1BBL dendritic cells.

  4. vaccination with recombinant attenuated Salmonella harboring the CEACAM6 and 4-1BBL gene efficiently increased the number of CD3 (show CD3 Antibodies)+CD8 (show CD8A Antibodies)+ TIL (show TLR1 Antibodies) and NK cells, decreased the number of FOXP3 (show FOXP3 Antibodies) cells and inhibited the development of DMH (show DST Antibodies)-induced colorectal cancer

  5. Elevated plasma levels and monocyte-associated expression of CD137 (show TNFRSF9 Antibodies) ligand in patients with acute atherothrombotic stroke

  6. Hence, the targeted combination of IL-15 (show IL15 Antibodies) and 4-BBL (show TP53 Antibodies) in the form of a trifunctional antibody-fusion protein is a promising new approach for cancer immunotherapy.

  7. monocytes interact with iNKT cells to increase expression of 4-1BBL and 4-1BB (show TNFRSF9 Antibodies), and in conjunction with this pathway, maintain their numbers at baseline.

  8. TIRAP (show TIRAP Antibodies) and IRAK2 (show IRAK2 Antibodies) are critical for the sustained inflammatory response that is mediated by late-phase signaling by the TLR-4 (show TLR4 Antibodies)-1BBL complex.

  9. this is the first study to indicate that this member of the TNF (show TNF Antibodies) superfamily, CD137 (show TNFRSF9 Antibodies), is modulated by SAHA treatment in breast

  10. Data show that TNFR1 (show TNFRSF1A Antibodies) associates with CD137L and is required for CD137L reverse signaling.

TNFSF9 Antigen Profile

Protein Summary

The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This transmembrane cytokine is a bidirectional signal transducer that acts as a ligand for TNFRSF9/4-1BB, which is a costimulatory receptor molecule in T lymphocytes. This cytokine and its receptor are involved in the antigen presentation process and in the generation of cytotoxic T cells. The receptor TNFRSF9/4-1BB is absent from resting T lymphocytes but rapidly expressed upon antigenic stimulation. The ligand encoded by this gene, TNFSF9/4-1BBL, has been shown to reactivate anergic T lymphocytes in addition to promoting T lymphocyte proliferation. This cytokine has also been shown to be required for the optimal CD8 responses in CD8 T cells. This cytokine is expressed in carcinoma cell lines, and is thought to be involved in T cell-tumor cell interaction.

Gene names and symbols associated with TNFSF9

  • tumor necrosis factor (ligand) superfamily, member 9 (Tnfsf9) antibody
  • tumor necrosis factor (ligand) superfamily, member 9 (TNFSF9) antibody
  • 4-1BB-L antibody
  • 4-1BBL antibody
  • AI848817 antibody
  • CD137L antibody
  • Ly63l antibody
  • TNFSF9 antibody

Protein level used designations for TNFSF9

costimulatory molecule , tumor necrosis factor (ligand) superfamily, member 9 , 4-1BB ligand , tumor necrosis factor ligand superfamily member 9 , 4-1BBL , homolog of mouse 4-1BB-L , receptor 4-1BB ligand

GENE ID SPECIES
353218 Rattus norvegicus
476729 Canis lupus familiaris
521748 Bos taurus
21950 Mus musculus
8744 Homo sapiens
Selected quality suppliers for anti-TNFSF9 (TNFSF9) Antibodies
Did you look for something else?